LONDON, April 12, 2016 /PRNewswire/ -- Smith &
Nephew (LSE:SN, NYSE:SNN), the global medical technology business,
today announced that it has been awarded a group purchasing
agreement for the Skin Integrity: Prevention, Healing and Support
category with Premier, Inc. Effective April
1, 2016, the new agreement allows Premier members, at their
discretion, to take advantage of special pricing and terms
pre-negotiated by Premier for Smith & Nephew's Advanced Wound
Care products, including the ALLEVYN™ family of hydrocellular foam
dressings, SECURA™ skin care system and ACTICOAT™ silver-coated
antimicrobial barrier dressings.
"Smith & Nephew is a leader in wound care and understands
that patients with wounds face many challenges. We are uniquely
positioned to provide wound care solutions through our portfolio of
products, clinical education, and support across the continuum of
care," said François Fournier, President, U.S. Commercial, Advanced
Wound Management at Smith & Nephew. "This new agreement with
Premier exemplifies our commitment to patients and healthcare
providers to secure wider access to our technologies for more
customers."
About Premier
Premier is a leading healthcare
improvement company, uniting an alliance of approximately 3,600
hospitals and 120,000 other providers to transform healthcare.
About Smith & Nephew Advanced Wound
Management
Smith & Nephew's Advanced Wound
Management division provides high quality products, medical
education and services supporting initial wound bed preparation
through to full wound closure, enabling better outcomes for
patients and healthcare systems. As part of this portfolio, Smith
& Nephew offers:
ACTICOAT silver-coated antimicrobial barrier dressings
that may help clinicians take control of the risk of soft tissue
and surgical site infections.
ALLEVYN LIFE hydrocellular foam dressings with a unique
five-layer construction designed to both absorb fluids and
redistribute pressure, making it an ideal tool for wound management
and pressure ulcer prevention protocols.
SECURA proven, preventive skin care products
formulated with high-quality ingredients that define the standard
of care for prevention.
NO-STING SKIN PREP™ liquid film forming skin
protectant which can be used on intact or damaged skin to help
prevent moisture associated dermatitis,
incontinence associated dermatitis, friction and adhesive
trauma.
About Smith & Nephew
Smith & Nephew is a
global medical technology business dedicated to helping healthcare
professionals improve people's lives. With leadership positions in
Orthopaedic Reconstruction, Advanced Wound Management, Sports
Medicine and Trauma & Extremities, Smith & Nephew has
around 15,000 employees and a presence in more than 100 countries.
Annual sales in 2015 were more than $4.6
billion. Smith & Nephew is a member of the FTSE100
(LSE:SN, NYSE:SNN).
For more information about Smith & Nephew, please visit our
website www.smith-nephew.com, follow @SmithNephewplc on Twitter or
visit SmithNephewplc on Facebook.com.
Forward-looking Statements
This document may contain forward-looking statements that may
or may not prove accurate. For example, statements regarding
expected revenue growth and trading margins, market trends and our
product pipeline are forward-looking statements. Phrases such as
"aim", "plan", "intend", "anticipate", "well-placed", "believe",
"estimate", "expect", "target", "consider" and similar expressions
are generally intended to identify forward-looking statements.
Forward-looking statements involve known and unknown risks,
uncertainties and other important factors that could cause actual
results to differ materially from what is expressed or implied by
the statements. For Smith & Nephew, these factors include:
economic and financial conditions in the markets we serve,
especially those affecting health care providers, payers and
customers; price levels for established and innovative medical
devices; developments in medical technology; regulatory approvals,
reimbursement decisions or other government actions; product
defects or recalls or other problems with quality management
systems or failure to comply with related regulations; litigation
relating to patent or other claims; legal compliance risks and
related investigative, remedial or enforcement actions; disruption
to our supply chain or operations or those of our suppliers;
competition for qualified personnel; strategic actions, including
acquisitions and dispositions, our success in performing due
diligence, valuing and integrating acquired businesses; disruption
that may result from transactions or other changes we make in our
business plans or organisation to adapt to market developments; and
numerous other matters that affect us or our markets, including
those of a political, economic, business, competitive or
reputational nature. Please refer to the documents that Smith &
Nephew has filed with the U.S. Securities and Exchange Commission
under the U.S. Securities Exchange Act of 1934, as amended,
including Smith & Nephew's most recent annual report on Form
20-F, for a discussion of certain of these factors. Any
forward-looking statement is based on information available to
Smith & Nephew as of the date of the statement. All written or
oral forward-looking statements attributable to Smith & Nephew
are qualified by this caution. Smith & Nephew does not
undertake any obligation to update or revise any forward-looking
statement to reflect any change in circumstances or in Smith &
Nephew's expectations.
™ Trademark of Smith & Nephew.
Certain marks registered US Patent and Trademark Office.
Logo -
http://photos.prnewswire.com/prnh/20131030/CL06769LOGO
To view the original version on PR Newswire,
visit:http://www.prnewswire.com/news-releases/smith--nephew-awarded-skin-integrity-prevention-healing-and-support-category-agreement-with-premier-inc-300249696.html
SOURCE Smith & Nephew